Lipoprotein disorders causes: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) No edit summary |
|||
| Line 37: | Line 37: | ||
Secondary to some underlying "non-lipid" etiology | Secondary to some underlying "non-lipid" etiology | ||
*Type 2 [[diabetes mellitus]] | *Type 2 [[diabetes mellitus]] <ref name="pmid3893447">{{cite journal| author=Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A et al.| title=Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. | journal=Atherosclerosis | year= 1985 | volume= 55 | issue= 3 | pages= 259-66 | pmid=3893447 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3893447 }} </ref> | ||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Chronic renal failure]] | *[[Chronic renal failure]] | ||
Revision as of 13:17, 23 October 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hyperlipidemia can occur as either a primary event or secondary to some underlying disease. The primary hyperlipidemias include chylomicronemia, hypercholesterolemia, dysbetalipoproteinemia, hypertriglyceridemia, mixed hyperlipoproteinemia, and combined hyperlipoproteinemia. Other diseases, such as diabetes mellitus, pancreatitis, renal disease, and hypothyroidism, can cause the secondary form.
Causes
Primary hyperlipidemia
Hyperlipoproteinemia type I
- Deficiency of lipoprotein lipase (LPL) or altered apolipoprotein C2
Hyperlipoproteinemia type II
Type IIa
- Familial hypercholesterolemia
- Sporadic (due to dietary factors)
- Polygenic (multiple abnormalities in LDL metabolism)
- Truly familial (as a result of a mutation in the LDL receptor gene on chromosome 19 (0.2% of the population), the apo B gene (0.2%) or the proprotein convertase subtilisin kexin 9 (PCSK9) gene (very rare))
Type IIb
- Familial combined hyperlipoproteinemia (FCH)
- Overproduction of hepatically-derived apo B-100 associated with VLDL
- Overproduction of substrates, including triglycerides and acetyl-CoA
- Decreased clearance of LDL
Hyperlipoproteinemia type III
- Presence of apo E E2/E2 genotype resulting in cholesterol-rich VLDL (β-VLDL)
Hyperlipoproteinemia type IV
- Genetic defect, which is passed on in an autosomal dominant fashion
Hyperlipoproteinemia type V
- Very similar to type I, but with high VLDL in addition to chylomicrons
- Associated with glucose intolerance and hyperuricemia
Secondary hyperlipidemia
Secondary to some underlying "non-lipid" etiology
- Type 2 diabetes mellitus [1]
- Nephrotic syndrome
- Chronic renal failure
- Cholestatic liver diseases
- Hypothyroidism
- Smoking
- Obesity
- Drugs
- Oral estrogens
- Thiazide diuretics
- Beta blockers
- Atypical antipsychotic agents, such as clozapine and olanzapine
- Antiretroviral drugs used for HIV infection, in particular the protease inhibitors
References
- ↑ Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A; et al. (1985). "Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride". Atherosclerosis. 55 (3): 259–66. PMID 3893447.